PMID- 27882107 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 1792-0981 (Print) IS - 1792-1015 (Electronic) IS - 1792-0981 (Linking) VI - 12 IP - 5 DP - 2016 Nov TI - Effects of sitagliptin as initial therapy in newly diagnosed elderly type 2 diabetics: A randomized controlled study. PG - 3002-3008 AB - The objective of this study was to investigate the characteristics of blood glycemic excursion, incretins and pancreatic hormone secretion in elderly people with newly diagnosed type 2 diabetes mellitus (T2DM) and to study the effects of sitagliptin on glycemic excursion in these subjects. A total of 129 newly diagnosed T2DM patients were enrolled in the study from March 2012 to August 2013. Clinical data, serum incretin, pancreatic hormone and continuous glucose monitoring data were collected. Among these subjects, elderly patients (NEDM) randomly received metformin combined with sitagliptin phosphate or glimepiride for 24 weeks. The blood glucose, glycosylated hemoglobin A(1c) (GHbA(1c)), serum incretins and pancreatic hormone levels were determined. During the oral glucose tolerance test (OGTT), 30 min insulin and C-peptide levels, 120 min insulin levels and ratio of the increases of insulin and blood glucose levels after 30 min of sugar loading (∆Ins30/∆Glu30) were significantly lower in elderly patients than in middle-aged patients (P<0.05). In addition, the glucagon elevation at 30 min was higher and the glucagon-like peptide-1 (GLP-1) at 30 min was lower in the elderly patients (P<0.05). Glucose excursion indices, including the standard deviation of the average blood glucose, intraday mean average glucose excursions (MAGE), and mean of daily differences (MODD), were significantly higher in the elderly patients (P<0.05). During the OGTT, insulin, C-peptide and ∆Ins30/∆Glu30 results at 30 min and GLP-1 levels at 120 min in NEDM subjects were significantly increased (P<0.05) and glucagon levels at 30 min was significantly lower after sitagliptin treatment (P<0.05) compared with glimepiride. Moreover, MAGE and MODD were significantly lower in the sitagliptin group after treatment compared to those in the glimepiride group (P<0.05). No severe hypoglycemia or cardiovascular diseases were observed. Strong blood glucose excursions occur in elderly patients with newly diagnosed T2DM. Sitagliptin phosphate combined with metformin effectively and safely improves glycemic excursion and carbohydrate metabolism in NEDM patients by promoting the first phase of insulin and incretin secretion and inhibiting glucagon secretion of. FAU - Xiao, Xiaoyan AU - Xiao X AD - Department of Nephrology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Cui, Xiaopei AU - Cui X AD - Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Zhang, Jianbo AU - Zhang J AD - Department of Emergency, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Han, Zhenxia AU - Han Z AD - Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Xiao, Yu AU - Xiao Y AD - Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Chen, Nan AU - Chen N AD - Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Li, Baoying AU - Li B AD - Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Cheng, Mei AU - Cheng M AD - Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Gao, Haiqing AU - Gao H AD - Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Tang, Kuanxiao AU - Tang K AD - Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China. LA - eng PT - Journal Article DEP - 20160920 PL - Greece TA - Exp Ther Med JT - Experimental and therapeutic medicine JID - 101531947 PMC - PMC5103735 OTO - NOTNLM OT - elderly OT - glycemic excursion OT - incretins OT - sitagliptin OT - type 2 diabetes EDAT- 2016/11/25 06:00 MHDA- 2016/11/25 06:01 PMCR- 2016/09/20 CRDT- 2016/11/25 06:00 PHST- 2015/05/21 00:00 [received] PHST- 2016/09/06 00:00 [accepted] PHST- 2016/11/25 06:00 [entrez] PHST- 2016/11/25 06:00 [pubmed] PHST- 2016/11/25 06:01 [medline] PHST- 2016/09/20 00:00 [pmc-release] AID - ETM-0-0-3729 [pii] AID - 10.3892/etm.2016.3729 [doi] PST - ppublish SO - Exp Ther Med. 2016 Nov;12(5):3002-3008. doi: 10.3892/etm.2016.3729. Epub 2016 Sep 20.